Efinopegdutide vs Dulaglutide

Head-to-head comparison of Efinopegdutide (Efinopegdutide (HM12525A), long-acting glucagon-like peptide-1/glucagon receptor dual agonist) and Dulaglutide (Recombinant GLP-1 receptor agonist Fc fusion protein) — benefits, dosing, side effects, research data, and where to buy.

Research Score

PropertyEfinopegdutideDulaglutide
CategoryWeight ManagementWeight Management
Full NameEfinopegdutide (HM12525A), long-acting glucagon-like peptide-1/glucagon receptor dual agonistRecombinant GLP-1 receptor agonist Fc fusion protein
Molecular WeightN/A~63,000 Da
Half-LifeApproximately 1 weekAbout 5 days
Amino AcidsN/AN/A
Typical DoseTrial-dependent; weekly SC dosing0.75-4.5 mg weekly
RouteSubcutaneousSubcutaneous
Purity≥98%≥98%
Studies Count14700
Research StatusClinicalApproved

Efinopegdutide Benefits

  • ✓reduced body weight
  • ✓improved insulin sensitivity
  • ✓reduced liver fat
  • ✓greater satiety

Dulaglutide Benefits

  • ✓modest weight loss
  • ✓lower A1c
  • ✓weekly dosing convenience
  • ✓cardiometabolic benefit

Efinopegdutide Dosing

once-weekly subcutaneous injection|dose escalation during lead-in|maintenance dosing in trials

Dulaglutide Dosing

0.75-4.5 mg SC weekly|Increase based on response and tolerance|Administer on the same day each week

Efinopegdutide Side Effects

  • ⚠nausea
  • ⚠decreased appetite
  • ⚠fatigue

Dulaglutide Side Effects

  • ⚠nausea
  • ⚠diarrhea
  • ⚠injection-site reactions

Research Overview

Efinopegdutide

Human trials have shown meaningful weight loss and improvements in hepatic steatosis biomarkers. It remains a research compound with ongoing development in metabolic disease.

Dulaglutide

Dulaglutide has repeatedly shown small-to-moderate reductions in body weight alongside glycemic improvement in large diabetes trials. It is a useful comparator for GLP-1 receptor agonist effects on appetite and weight.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

Efinopegdutide stacks with:

metforminorlistat

Dulaglutide stacks with:

metformindiet-and-exercise
glp1glucagondual-agonistobesitynashGLP-1RAweekly-injectiontype-2-diabetesmodest-weight-loss